ACCEPT:

•  If donor had successful ablation therapy for Wolf-Parkinson-White syndrome (WPW) if they are well and asymptomatic and it has been confirmed that the ablation was successful.

DEFER:

• If under investigation for an arrhythmia until results are available.

PERMANENTLY EXCLUDE:

• If the donor is symptomatic or on treatment or the ablation was unsuccessful.

ADDITIONAL INFORMATION 

Wolff-parkinson-white pattern, or WPW, is a type of heart arrhythmia caused by an accessory pathway, or an “extra” electrical conduction pathway connecting the atria and ventricles, or upper and lower chambers of the heart. About 60% of people with the electrical problem developed symptoms, which may include an abnormally fast heartbeat, palpitations, shortness of breath, lightheadedness, or syncope. Rarely, cardiac arrest may occur. The most common type of irregular heartbeat that occurs is known as paroxysmal supraventricular tachycardia.

WPW syndrome may be monitored or treated with either medications or an ablation (destroying the tissues) such as with radiofrequency catheter ablation.